Xenon Pharmaceuticals (($XENE)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Multicenter, ...
Focal treatment-resistant epilepsy improves over time, but seizure reduction appears to be unrelated to specific medications ...
Medpage Today on MSN
Epilepsy Treatment Resistance May Fade Over Time
Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Focal treatment-resistant epilepsy ...
A new study has brought scientists one step further in the direction of developing a cure for a brutal group of rare brain ...
TipRanks on MSN
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
ONO Pharmaceutical Co (($OPHLF)) announced an update on their ongoing clinical study. Study Overview: ONO Pharmaceutical Co. Ltd is conducting a ...
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...
12don MSN
Innovation in epilepsy care: Alternatives to medication seek to reset, repair brain, expert explains
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...
KANSAS CITY, Mo. (KCTV) - A U.S. Senator from Missouri has joined a coalition to introduce the National Plan for Epilepsy to encourage new treatment options and search for a cure. Recently, U.S.
News-Medical.Net on MSN
New study offers hope for patients with treatment-resistant focal epilepsy
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...
Medics Warn Against Unauthorised, Unscientific Treatment Of Epilepsy. KABUL (Pajhwok): Specialists in mental and neurological ...
Chicago, Feb. 06, 2018 (GLOBE NEWSWIRE) -- New research, funded by Citizens United for Research in Epilepsy (CURE), has discovered a ‘smoking gun’ biomarker that could result in treatments that stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results